Renoprotective properties of resveratrol in the treatment of renal fibrosis, renal cell carcinoma, diabetic nephropathy and nephrotoxicity: a review of current evidence based on underlying cellular mechanisms.
1/5 보강
Chronic kidney disease and its complications, including renal fibrosis, diabetic nephropathy, and renal cell carcinoma represent a major global health burden with limited therapeutic options.
APA
AlRamadneh TN, Abdulsahib WK, et al. (2026). Renoprotective properties of resveratrol in the treatment of renal fibrosis, renal cell carcinoma, diabetic nephropathy and nephrotoxicity: a review of current evidence based on underlying cellular mechanisms.. Toxicology mechanisms and methods, 36(3), 354-375. https://doi.org/10.1080/15376516.2025.2598564
MLA
AlRamadneh TN, et al.. "Renoprotective properties of resveratrol in the treatment of renal fibrosis, renal cell carcinoma, diabetic nephropathy and nephrotoxicity: a review of current evidence based on underlying cellular mechanisms.." Toxicology mechanisms and methods, vol. 36, no. 3, 2026, pp. 354-375.
PMID
41347316 ↗
Abstract 한글 요약
Chronic kidney disease and its complications, including renal fibrosis, diabetic nephropathy, and renal cell carcinoma represent a major global health burden with limited therapeutic options. Resveratrol, a naturally occurring polyphenol found in grapes and berries, has emerged as a promising therapeutic candidate due to its multifaceted biological activities. Extensive research demonstrates resveratrol's remarkable renoprotective properties across various renal pathologies. It effectively attenuates tissue scarring, mitigates diabetes-related kidney damage, inhibits cancer progression, and protects against drug-induced nephrotoxicity. These broad-spectrum benefits stem from its unique ability to simultaneously target oxidative stress, inflammation, angiogenesis, apoptosis, and cellular damage pathways. Clinical investigations have confirmed resveratrol's potential to improve renal function markers in patients, while advanced formulation strategies are enhancing its therapeutic effectiveness. The compound's excellent safety profile further supports its clinical translation potential. This comprehensive review evaluates the current evidence for the renoprotective effects of resveratrol, focusing on its mechanisms of action in kidney diseases.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.